Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.
about
The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applicationsEffective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T CellsHead and Neck Carcinoma Immunotherapy: Facts and Hopes.Establishment of Synergistic Chemoimmunotherapy for Head and Neck Cancer Using Peritumoral Immature Dendritic Cell Injections and Low-Dose Chemotherapies.
P2860
Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.
@en
type
label
Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.
@en
prefLabel
Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.
@en
P2093
Jonas T Johnson
Joseph Kiss
Miroslaw Szczepanski
Mitchell Tublin
Rita Johnson
Robert L Ferris
Theresa L Whiteside
P2860
P304
P356
10.1002/HED.24025
P478
38 Suppl 1
P577
2015-03-03T00:00:00Z